Boston Scientific (BSX) PT Lowered to $57 at Raymond James
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Raymond James lowers BSX target to $57; price $46.04; solid upside.
Target: $57
Posted price: $46.04
Analyst firm: Raymond James
Analyst: Jayson Bedford
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.